Inhibikase Therapeutics Inc (IKT)
SBC to Revenue
0.00%
Quarterly · Period ending:
IKT SBC to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
IKT Quarterly SBC/Revenue (30.39% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
IKT sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 12,224,900% | |
| 163.105% | |
| 107.2459% | |
| 191.0617% | |
| 157.8879% | |
| 1,396.0774% | |
| 2,026.3584% | |
| 267.7087% | |
| 13,675.4115% | |
| 107.2947% | |
| 23.6592% | |
| 42.0082% | |
| 90.6136% | |
| 370.9076% | |
| 0% | |
| 51.6118% | |
| 58.4157% | |
| 700.8109% | |
| 54.5675% | |
| 56.358% | |
| 0% | |
| 24.0994% | |
| 0% | |
| 30.3928% |